Evaluating the Clinical and Immune Response to Two Dengue Virus Vaccines in Healthy Adults

Summary

Dengue viruses infect millions of people throughout the tropics and subtropics each year. The development of a dengue vaccine is an important health priority. This study will evaluate the immunologic and clinical response to two dengue vaccines, given 9 months apart, in healthy adults with no history of previous flavivirus infection.

Timeline

Start

2015-03

Primary completion

2016-07

Completion

2017-02

Drugs

Indications